Platelets Indices and Its Role to Predict Liver Fibrosis in Patients With Chronic Hepatitis B Infection

NCT05567614 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2022-10-05

No results posted yet for this study

Summary

Platelets indices and its role to predict liver Fibrosis in patients with chronic hepatitis B infection

Conditions

  • Fibrosis, Liver

Interventions

RADIATION

Liver Fibroscan

Patients with CHB virus will do liver fibroscan and correlat between platelets count and degree of liver fibrosis

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Ahmed AB Maghraby, Professor · Assiut University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-20
Primary Completion
2023-08-15
Completion
2023-12-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05567614 on ClinicalTrials.gov